α-SMA, an activation marker of hepatic stellate cells, is overexpressed in NASH which was partly reversed by OCA, but the relative expression of ACTA2 is not altered by OCA. The gene discussed is ACTA1; the disease is metabolic dysfunction-associated steatohepatitis.